BioStrand
BioStrand is a biotech company revolutionizing biotherapeutics and drug development through advanced artificial intelligence and its proprietary LENSai™ Integrated Intelligence Technology, powered by HYFTs®. This technology seamlessly integrates massive data from diverse sources to accelerate drug discovery, offering an end-to-end fusion of in vitro, in vivo, and in silico technologies. Their platform provides a unified data view for rapid insights, security, traceability, and collaboration, utilizing proprietary algorithms and HYFTs, a novel computational language, for detailed and scalable insights. BioStrand partners with pharmaceutical and technology companies to solve complex drug discovery challenges, aiming to transform the pace and precision of antibody discovery for better patient outcomes. They offer various access models including fee-for-service, cloud-based SaaS, API deployment, and strategic partnerships.
BioStrand
BioStrand is a biotech company revolutionizing biotherapeutics and drug development through advanced artificial intelligence and its proprietary LENSai™ Integrated Intelligence Technology, powered by HYFTs®. This technology seamlessly integrates massive data from diverse sources to accelerate drug discovery, offering an end-to-end fusion of in vitro, in vivo, and in silico technologies. Their platform provides a unified data view for rapid insights, security, traceability, and collaboration, utilizing proprietary algorithms and HYFTs, a novel computational language, for detailed and scalable insights. BioStrand partners with pharmaceutical and technology companies to solve complex drug discovery challenges, aiming to transform the pace and precision of antibody discovery for better patient outcomes. They offer various access models including fee-for-service, cloud-based SaaS, API deployment, and strategic partnerships.